Cargando…
The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease (ILD) with limited treatment options. Interleukin-33 (IL-33) is proposed to play a role in the development of IPF however the exclusive use of prophylactic dosing regimens means that the therapeutic benefit of...
Autores principales: | Stephenson, Katherine E., Porte, Joanne, Kelly, Aoife, Wallace, William A., Huntington, Catherine E., Overed-Sayer, Catherine L., Cohen, E. Suzanne, Jenkins, R. Gisli, John, Alison E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035257/ https://www.ncbi.nlm.nih.gov/pubmed/36949463 http://dx.doi.org/10.1186/s12931-023-02334-4 |
Ejemplares similares
-
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
por: Cohen, E. Suzanne, et al.
Publicado: (2015) -
Assessment of the effect of potential antifibrotic compounds on total and αVβ6 integrin‐mediated TGF‐β activation
por: Porte, Joanne, et al.
Publicado: (2014) -
Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles
por: Asghar, Sabha, et al.
Publicado: (2023) -
Are mast cells instrumental for fibrotic diseases?
por: Overed-Sayer, Catherine, et al.
Publicado: (2014) -
IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity
por: Yang, Libang, et al.
Publicado: (2018)